Combat Disorder

Categories: Mental diseases, Neuronal diseases

Aliases & Classifications for Combat Disorder

MalaCards integrated aliases for Combat Disorder:

Name: Combat Disorder 12 15
Combat Disorders 44 73
Combat Neurosis 12


External Ids:

Disease Ontology 12 DOID:6950
MeSH 44 D003130
NCIt 50 C34498
UMLS 73 C0009426

Summaries for Combat Disorder

Disease Ontology : 12 An acute stress disorder that involves neurotic reactions to unusual, severe, or overwhelming military stress.

MalaCards based summary : Combat Disorder, also known as combat disorders, is related to acute stress disorder. An important gene associated with Combat Disorder is DIS3 (DIS3 Homolog, Exosome Endoribonuclease And 3'-5' Exoribonuclease), and among its related pathways/superpathways are amb2 Integrin signaling and MSP-RON Signaling. The drugs Tramadol and Fluoxetine have been mentioned in the context of this disorder.

Related Diseases for Combat Disorder

Diseases related to Combat Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 acute stress disorder 8.2 ACKR1 DIS3 MST1 TRAF3IP2

Symptoms & Phenotypes for Combat Disorder

Drugs & Therapeutics for Combat Disorder

Drugs for Combat Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 43)
# Name Status Phase Clinical Trials Cas Number PubChem Id
Tramadol Approved, Investigational Phase 4 27203-92-5 33741
Fluoxetine Approved, Vet_approved Phase 4 54910-89-3 3386
Paroxetine Approved, Investigational Phase 4 61869-08-7 43815
4 Analgesics Phase 4
5 Central Nervous System Depressants Phase 4,Not Applicable
6 Serotonin Agents Phase 4
7 Serotonin Uptake Inhibitors Phase 4
8 Narcotics Phase 4
9 Neurotransmitter Agents Phase 4,Phase 1,Phase 2,Not Applicable
10 Analgesics, Opioid Phase 4
11 Neurotransmitter Uptake Inhibitors Phase 4
12 Cytochrome P-450 CYP2D6 Inhibitors Phase 4
13 Cytochrome P-450 Enzyme Inhibitors Phase 4
14 Peripheral Nervous System Agents Phase 4
15 Antidepressive Agents Phase 4
16 Antidepressive Agents, Second-Generation Phase 4
17 Psychotropic Drugs Phase 4
18 Quetiapine Fumarate Phase 4 111974-72-2
19 Tranquilizing Agents Phase 4
20 Antipsychotic Agents Phase 4
Serotonin Investigational, Nutraceutical Phase 4 50-67-9 5202
Hydrocortisone Approved, Vet_approved Phase 2, Phase 3 50-23-7 5754
23 Cortisol succinate Phase 2, Phase 3
24 Hydrocortisone 17-butyrate 21-propionate Phase 2, Phase 3
25 Hydrocortisone acetate Phase 2, Phase 3
Menthol Approved Phase 2,Not Applicable 2216-51-5 16666
Prazosin Approved Phase 1, Phase 2,Phase 2,Not Applicable 19216-56-9 4893
28 Adrenergic Agents Phase 1, Phase 2,Not Applicable
29 Adrenergic alpha-1 Receptor Antagonists Phase 1, Phase 2,Not Applicable
30 Adrenergic alpha-Antagonists Phase 1, Phase 2,Not Applicable
31 Adrenergic Antagonists Phase 1, Phase 2,Not Applicable
32 Antihypertensive Agents Phase 1, Phase 2,Not Applicable
33 Omega 3 Fatty Acid Nutraceutical Phase 2
Ethanol Approved Not Applicable 64-17-5 702
Cycloserine Approved Not Applicable 68-41-7 401 6234
36 Renal Agents Not Applicable
37 Nootropic Agents Not Applicable
38 Anti-Bacterial Agents Not Applicable
39 Antibiotics, Antitubercular Not Applicable
40 Anti-Infective Agents Not Applicable
41 Antitubercular Agents Not Applicable
42 Antimetabolites Not Applicable
43 Anti-Infective Agents, Local Not Applicable

Interventional clinical trials:

(show all 35)
# Name Status NCT ID Phase Drugs
1 Tramadol Extended-Release (ER) for Posttraumatic Stress Disorder (PTSD) Unknown status NCT01517711 Phase 4 Tramadol;Placebo
2 Predictors of Treatment Response to Fluoxetine in PTSD Following a Recent History of War Zone Stress Exposure Unknown status NCT00633685 Phase 4 Fluoxetine;Placebo
3 Quetiapine Augmentation for Treatment-resistant PTSD Completed NCT00292370 Phase 4 Open Label (OL) Paroxetine;Placebo;Quetiapine
4 A Head-to-head Comparison of Virtual Reality Treatment for Post Traumatic Stress Disorder Unknown status NCT00978484 Phase 3
5 Exposure Therapy for Chronic PTSD: Efficacy and Mechanisms Completed NCT00475241 Phase 2, Phase 3
6 Spouse READI (Resilience Education And Deployment Information) Post Deployment Telephone Support Groups Completed NCT01121250 Phase 2, Phase 3
7 Military to Civilian: Trial of an Intervention to Promote Postdeployment Reintegration Completed NCT00640445 Phase 2, Phase 3
8 Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders Unknown status NCT01216982 Phase 2 Lovaza, omega-3 fatty acid ethyl ester;Placebo, visually identical to Lovaza
9 Trauma Management Therapy for OEF and OIF Combat Veterans Completed NCT02809326 Phase 2
10 Chronic Postconcussive Headache: A Placebo-Controlled Treatment Trial of Prazosin Recruiting NCT02266329 Phase 1, Phase 2 prazosin hydrochloride;placebo
11 Exercise: A Novel Treatment for Combat Post Traumatic Stress Disorder Terminated NCT01626131 Phase 2
12 Trial of Oral SNC-102 in Subjects With Combat-Related Posttraumatic Stress Disorder Withdrawn NCT02384369 Phase 2 SNC-102 sustained release tablet
13 Telepharmacy Robotic Medicine Delivery Unit "TRMDU" Assessment Unknown status NCT01007006 Not Applicable
14 Prospective Study of Veteran Health in Previously Deployed Soldiers Completed NCT00285246
15 A Placebo-Controlled Trial of D-Cycloserine and Exposure Therapy for Combat-PTSD Completed NCT00371176 Not Applicable D-Cycloserine
16 Treatment of Older Veterans With Chronic Posttraumatic Stress Disorder Completed NCT00539279 Not Applicable
17 Psychotherapy Treatment of Deployment-Related PTSD in Primary Care Settings Completed NCT00974402 Not Applicable
18 Augmentation Trial of Prazosin for Post-Traumatic Stress Disorder (PTSD) Completed NCT00990106 Not Applicable prazosin hydrochloride;placebo
19 Reintegration: The Role of Spouse Telephone BATTLEMIND Pilot Study Completed NCT00870545 Not Applicable
20 Prolonged Exposure Versus Treatment as Usual in Chronic Posttraumatic Stress Disorder Combat and Terror Related Patients Completed NCT00229372 Not Applicable
21 Motivational Interviewing to Engage Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) Veterans in Mental Health Treatment Completed NCT00419029 Not Applicable
22 Integrated Treatment of OEF/OIF Veterans With PTSD & Substance Use Disorders Completed NCT01338506 Not Applicable
23 Comparing Virtual Reality Exposure Therapy to Prolonged Exposure Completed NCT01459705 Not Applicable
24 Exposure Therapy for Active Duty Soldiers With Post Traumatic Stress Disorder Completed NCT01193725 Not Applicable
25 Exploring Deployment Stress and Reintegration in Army National Guard Chaplains Completed NCT01330888
26 CBT for Aggression in Veterans Completed NCT02233517 Not Applicable
27 Examining the Effect of Acupuncture on Sleep Difficulties Related to Post Traumatic Stress Disorder Completed NCT00868517 Not Applicable
28 An Open-Trial of Web-Prolonged Exposure (Web-PE) Among Active-Duty Military Recruiting NCT03337750 Not Applicable
29 Prazosin Augmentation of Outpatient Treatment of Alcohol Use Disorders in Active Duty Soldiers With and Without PTSD Recruiting NCT02226367 Not Applicable prazosin hydrochloride;placebo
30 Vietnam Era Health Retrospective Observational Study Active, not recruiting NCT02825602
31 The Efficacy of 90-Minute Versus 60-Minute Sessions of Prolonged Exposure for PTSD Active, not recruiting NCT02720497 Not Applicable
32 A Comparison of Web-Prolonged Exposure (Web-PE) and Present-Centered Therapy (PCT) for PTSD Among Active-Duty Military Personnel Active, not recruiting NCT02556645 Not Applicable
33 Prolonged Exposure for Post Traumatic Stress Disorder (PTSD) Among Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) Personnel Active, not recruiting NCT01049516 Not Applicable
34 FOCUS-CI: A Preventive Intervention With Children and Families of the Combat Injured Terminated NCT01062022 Not Applicable
35 Effect of Prazosin on Neurophysiology and Cognition in Post-Traumatic Stress Disorder (PTSD) Withdrawn NCT00890643 Not Applicable prazosin hydrochloride;placebo

Search NIH Clinical Center for Combat Disorder

Cochrane evidence based reviews: combat disorders

Genetic Tests for Combat Disorder

Anatomical Context for Combat Disorder

Publications for Combat Disorder

Variations for Combat Disorder

Expression for Combat Disorder

Search GEO for disease gene expression data for Combat Disorder.

Pathways for Combat Disorder

Pathways related to Combat Disorder according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.94 MST1 MST1R
2 10.84 MST1 MST1R
3 10.45 MST1 MST1R
4 9.32 MST1 MST1R

GO Terms for Combat Disorder

Cellular components related to Combat Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 vacuole GO:0005773 8.62 MST1 MST1R

Biological processes related to Combat Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 defense response GO:0006952 8.96 ACKR1 MST1R
2 hepatocyte growth factor receptor signaling pathway GO:0048012 8.62 MST1 MST1R

Sources for Combat Disorder

9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
32 HPO
33 ICD10
34 ICD10 via Orphanet
38 LifeMap
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
55 Novoseek
58 OMIM via Orphanet
62 PubMed
70 SNOMED-CT via Orphanet
72 Tocris
74 UMLS via Orphanet
Loading form....